Abatacept in rheumatoid arthritis-associated interstitial lung disease: short-term outcomes and predictors of progression

Introduction Interstitial lung disease in rheumatoid arthritis (RA-ILD) is an extra-articular involvement that impairs the prognosis and for which there is still no well-coded treatment. The aim of this study was to evaluate abatacept (ABA) effectiveness and safety in patients with RA-ILD. Methods R...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical rheumatology 2021-12, Vol.40 (12), p.4861-4867
Hauptverfasser:	Tardella, Marika, Di Carlo, Marco, Carotti, Marina, Giovagnoni, Andrea, Salaffi, Fausto
Format:	Artikel
Sprache:	eng
Schlagworte:	Abatacept - therapeutic use Aged Antirheumatic Agents - therapeutic use Arthritis, Rheumatoid - complications Arthritis, Rheumatoid - drug therapy Computed tomography Disease Progression Female Fibrosis Humans Lung diseases Lung Diseases, Interstitial - diagnostic imaging Lung Diseases, Interstitial - drug therapy Male Medicine Medicine & Public Health Methotrexate Methotrexate - therapeutic use Middle Aged Original Original Article Patients Respiratory function Rheumatoid arthritis Rheumatology Smoking
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!